Toggle navigation
Home
Technology
CytoComm™ Platform
Preclinical
Oncology
Cardiology
Partners
News & Media
About
Management Team
Board of Directors
Advisors
Careers
Contact
Efferent Labs Signs Agreement With Evotec AG To Continue Development Of Groundbreaking Medical Diagnostic Product
Press Releases
Efferent Labs Signs Agreement With Evotec AG To Continue Development Of Groundbreaking Medical Diagnostic Product
Toggle navigation
Featured In
Categories
News
Press Releases
Recent Posts
Efferent Labs Taps Evotec to Advance Implantable Biosensor for R&D, Oncology
Efferent Labs Signs Agreement With Evotec AG To Continue Development Of Groundbreaking Medical Diagnostic Product
Efferent CEO To Present At MedTech 2016
Life-Sciences Accelerator Program Selects Efferent Labs
Could a Biosensor Help Personalize Cancer Treatment?
Archives
January 2017
September 2016
April 2016
February 2016
October 2015
September 2015
August 2015
June 2015
May 2015
February 2015
November 2014
October 2014
August 2014
July 2014
May 2012
March 2012
November 2011
Efferent Labs Signs Agreement With Evotec AG To Continue Development Of Groundbreaking Medical Diagnostic Product
Jan 09, 2017
0 comments
January 9, 2017
FOR MORE INFORMATION CONTACT:
press@efferentlabs.com
Download the Press Release